CGBC 02 was derived from patient No. 2, a 44-year-old Taiwanese woman with grade III invasive ductal carcinoma and was ER (1 +), PR (3 +) and HER2 (−) (Table 1). This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.